3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia
22
Lymphoma
14
Leukemia, Myeloid, Acute
14
Myelodysplastic Syndromes
12
Leukemia, Lymphocytic, Chronic, B-Cell
12
Breast Neoplasms
11
Prostatic Neoplasms
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
9
Multiple Myeloma
9
Melanoma
9
Lymphoma, Follicular
9
Neuroblastoma
8
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
8
Ovarian Neoplasms
7
Congenital Abnormalities
7
Lymphoma, Non-Hodgkin
6
Hodgkin Disease
5
Neoplasms, Plasma Cell
4
Neoplasm Metastasis
4
Myeloproliferative Disorders
4
Lymphoma, Mantle-Cell
4
Leukemia, Myeloid, Chronic-Phase
4
Glioblastoma
4
Fallopian Tube Neoplasms
4
Anemia, Refractory, with Excess of Blasts
4
Waldenstrom Macroglobulinemia
3
Osteosarcoma
3
Lymphoma, Large-Cell, Immunoblastic
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, B-Cell, Marginal Zone
3
Interventions
Tacrolimus
29
fludarabine phosphate
21
Methotrexate
21
Cyclophosphamide
21
Mycophenolic Acid
18
Busulfan
15
Antilymphocyte Serum
14
Whole-Body Irradiation
13
Sirolimus
12
fludarabine
11
Peripheral Blood Stem Cell Transplantation
11
Cyclosporine
9
thymoglobulin
8
Melphalan
8
Hematopoietic Stem Cell Transplantation
6
Granulocyte Colony-Stimulating Factor
6
Filgrastim
6
Rituximab
5
Pentostatin
5
Methylprednisolone
5
Thiotepa
4
Stem Cell Transplantation
4
Radiotherapy
4
Cyclosporins
4
ruxolitinib
3
Vorinostat
3
Transplantation
3
Flow Cytometry
3
Etoposide
3
merphos
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Graft vs Host Disease
×
sargramostim
×
Clear all
No trials found.